Laboratorios Farmaceuticos Rovi, S.A. (VIE:ROVI)
Austria flag Austria · Delayed Price · Currency is EUR
73.00
-0.65 (-0.88%)
Last updated: Jan 28, 2026, 1:00 PM CET

VIE:ROVI Balance Sheet

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
49.2527.1925.32124.9599.0453.16
Short-Term Investments
-0.830.110.090.10.07
Cash & Short-Term Investments
49.2528.0225.44125.0399.1453.23
Cash Growth
180.56%10.15%-79.66%26.13%86.22%-21.14%
Accounts Receivable
191.39114.83124.55160.23129.863.34
Other Receivables
0.1212.6115.9121.0627.8318.61
Receivables
191.51127.44140.46181.28157.6381.95
Inventory
314.79329.95337.97311.94245.47227.2
Prepaid Expenses
3.652.692.732.031.790.01
Other Current Assets
-1.512.742.792.332.18
Total Current Assets
559.19489.61509.33623.07506.36364.58
Property, Plant & Equipment
304.63286.62253.65215.54181.78155.4
Long-Term Investments
19.1119.520.592.22.071.88
Other Intangible Assets
35.528.2327.7429.1431.5133.93
Long-Term Deferred Tax Assets
3.582.262.342.083.8511.11
Long-Term Deferred Charges
-5.726.166.67.057.49
Other Long-Term Assets
0.070.070.070.070.070.07
Total Assets
922.07832.02799.88878.7732.68574.44
Accounts Payable
102.2389.93109.89125.8799.465.19
Accrued Expenses
-33.1928.8331.6724.623.85
Current Portion of Long-Term Debt
26.3117.848.068.272.982.95
Current Portion of Leases
-5.855.134.463.443.07
Current Income Taxes Payable
22.422.385.26-0.68-
Current Unearned Revenue
34.475.2539.51115.3958.1225.5
Other Current Liabilities
-2.213.178.231.172.33
Total Current Liabilities
185.42156.65199.84293.89190.39122.89
Long-Term Debt
85.1280.538.5846.0452.5253.94
Long-Term Leases
12.210.2213.6713.414.2214.48
Long-Term Unearned Revenue
5.642.752.793.323.798.5
Long-Term Deferred Tax Liabilities
0.710.371.520.680.780.93
Total Liabilities
289.27250.48256.39357.32261.7200.74
Common Stock
3.073.073.243.243.363.36
Additional Paid-In Capital
87.6487.6487.6487.6487.6487.64
Retained Earnings
536.06486.89556.21456.7446.1302.89
Treasury Stock
-4.98-5.55-107.68-27.56-66.12-20.19
Comprehensive Income & Other
-0.05-0.02-0.02-0.01-0-0
Total Common Equity
621.74572.03539.39520.01470.98373.7
Minority Interest
11.069.514.111.37--
Shareholders' Equity
632.8581.54543.49521.38470.98373.7
Total Liabilities & Equity
922.07832.02799.88878.7732.68574.44
Total Debt
123.62114.4165.4372.1773.1674.44
Net Cash (Debt)
-74.37-86.39-39.9952.8725.97-21.21
Net Cash Growth
---103.55%--
Net Cash Per Share
-1.45-1.69-0.750.990.47-0.38
Filing Date Shares Outstanding
51.1551.1551.8253.3754.8555.4
Total Common Shares Outstanding
51.1551.1551.8253.3754.8555.4
Working Capital
373.77332.96309.49329.19315.97241.69
Book Value Per Share
12.1611.1810.419.748.596.75
Tangible Book Value
586.24543.8511.65490.87439.46339.77
Tangible Book Value Per Share
11.4610.639.879.208.016.13
Land
-74.860.6545.1237.2535.75
Machinery
-404.19372.97303.78275.44250.22
Construction In Progress
-11.018.4740.1728.0614.68
Source: S&P Global Market Intelligence. Standard template. Financial Sources.